Insight Health Projects Limited 14155472 false 2022-06-07 2023-06-30 2023-06-30 The principal activity of the company is to carry out eating disorder research projects for the NHS. Digita Accounts Production Advanced 6.30.9574.0 true 14155472 2022-06-07 2023-06-30 14155472 2023-06-30 14155472 core:CurrentFinancialInstruments core:WithinOneYear 2023-06-30 14155472 bus:Micro-entities 2022-06-07 2023-06-30 14155472 bus:AuditExemptWithAccountantsReport 2022-06-07 2023-06-30 14155472 bus:FullAccounts 2022-06-07 2023-06-30 14155472 bus:SmallCompaniesRegimeForAccounts 2022-06-07 2023-06-30 14155472 bus:Director2 2022-06-07 2023-06-30 14155472 bus:PrivateLimitedCompanyLtd 2022-06-07 2023-06-30 14155472 countries:AllCountries 2022-06-07 2023-06-30 iso4217:GBP xbrli:pure

Registration number: 14155472

Insight Health Projects Limited

Annual Report and Unaudited Financial Statements

for the Period from 7 June 2022 to 30 June 2023

 

Insight Health Projects Limited

(Registration number: 14155472)
Balance Sheet as at 30 June 2023

2023
£

Fixed assets

3,771

Current assets

7,408

Creditors: Amounts falling due within one year

(1,229)

Net current assets

6,179

Total assets less current liabilities

9,950

Accruals and deferred income

(840)

 

9,110

Capital and reserves

9,110

1

Staff numbers

The average number of persons employed by the Company (including Directors) during the period, was 4.

For the financial period ending 30 June 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the Company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the Board on 4 March 2024 and signed on its behalf by:
 

Dr Suzanne Mary Heywood-Everett
Director